Description
Vorinostat, marketed under the brand name ZOLINZA, It is an prescription medication that has been approved vorinostat (Zolinza) on October 6, 2006 for the treatment of cutaneous T-cell lymphoma (CTCL).
What is ZOLINZA (vorinostat) ?
ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for:
Treatment of cutaneous manifestations in patients with cutaneous Tcell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies.
How to order approved “ZOLINZA (vorinostat) for Capsules” Medicine?
ZOLINZA (Vorinostat) Capsules is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing ZOLINZA and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.





